ישראל - עברית - Ministry of Health

kamada ltd - heparin as sodium 100 iu/ml - solution for injection - heparin - to maintain patency of an indwelling intravenous catheter designed for intermittent injection or blood sampling.

ישראל - עברית - Ministry of Health

medic trim healthcare ltd - heparin sodium 5000 iu/ml - solution for injection - heparin - anticoagulant, treatment of arterial and venous thrombosis, prevention of thromo-embolic complications after surgery.

ישראל - עברית - Ministry of Health

kamada ltd - heparin as sodium 10 iu/ml - solution for injection - heparin - intended to maintain potency of indweling i.v. catheter designed for intermittent injection therapy of blood sampling. may be used following initial placement of the device in the vein, an injection of a medication or after withdrawal of blood for laboratory analysis.

ישראל - עברית - Ministry of Health

teva medical ltd - heparin sodium - תמיסה לאינפוזיה - heparin sodium 2 u/ml - heparin - heparin - anticoagulant in extracorporeal circulation, dialysis procedures, an aid in the maintenance of catheter patency.

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - heparin sodium 200 iu / 100 ml - solution for injection - heparin - as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.

ישראל - עברית - Ministry of Health

pharmalogic ltd - heparin sodium - תמיסה להזרקה\אינפוזיה - heparin sodium 5000 iu/ml - heparin - heparin - treatment of thrombo-embolic disorders as deep vein thrombosis, acute arterial embolism or thrombosis, thrombophlebitis, pulmonary embolism , fat embolism. prophylaxis of deep vein thrombosis and thromboembolic events.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - תמיסה להזרקה - dalteparin sodium 5000 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism.unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - תמיסה להזרקה - dalteparin sodium 2500 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - תמיסה להזרקה - dalteparin sodium 2500 iu/ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections. cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

ישראל - עברית - Ministry of Health

sanofi israel ltd - enoxaparin sodium - תמיסה להזרקה - enoxaparin sodium 100 mg/ml ml - enoxaparin - enoxaparin - enoxaparin sodium is an anti-coagulant. at dosesof 20 mg and 40 mg it is indicated for: - prophylactic treatment of thrombo-embolic disorders of venous origin and in particular in orthopedic surgery or in general surgery. - prevention of thrombus formation in the extra-corporeal circulation during hemodialysis. at dosege of 40 mg the indications are: - prophylactic treatment of deep vein thrombosis in patients who are bedridden due to an acute medial disorder: - heart failure (hyha class iii or iv) - acute respiratory failure - episode of acute infection or acute rheumatic disorder combined with at least one other venous thromboembolic risk factor. at high doses of 60, 80 ,100 mg clexan is indicated for: -treatment of deep vein thrombosis (dvt). - treatment of unstable angina and non-q-wave myocardial infaction administered concurrently with aspirin. - treatment of pulmonary embolism.treatment of acute st- segment elevation myocardial infarction, in combination with a thrombolytic agent in patients eligible o